Usa Britain Argentina Brazil county Hill Mexico Sweden city Oxford city Adrian, county Hill covid-19 vaccine Government bill Usa Britain Argentina Brazil county Hill Mexico Sweden city Oxford city Adrian, county Hill

Oxford COVID-19 vaccine: Human trials to end by November, mass production from 2021

Reading now: 837
www.livemint.com

COVID-19 vaccine developed by the University of Oxford will be completed by the end of November of early December, an official said.

University of Oxford joined hands with British Swedish firm Astrazeneca to make a COVID 19 vaccine. The phase III trial has already started in United States and Brazil.

The vaccine has shown promising results in the first phase of clinical human trial. The researchers said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55. “We are seeing good immune response in almost everybody," said Dr Adrian Hill, director of the Jenner Institute at Oxford University.Under an agreement between Mexican and Argentine governments and drugmaker, AstraZeneca may start.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA